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Takotsubo Cardiomyopathy-More than just a broken heart?
Ragbeer, D. DO, Cronovich, H. DO
Department of Emergency Medicine, Henry Ford Macomb Hospital, Clinton Township, MI
Henry Ford Health System, Detroit, Michigan
Introduction

Diagrams

Takotsubo cardiomyopathy, also known as “stress cardiomyopathy” or “broken
heart syndrome” will likely not be definitely diagnosed in the emergency
department. However the typical patient is a common ED visitor: postmenopausal females presenting with chest pain or difficulty in breathing leading
to an ACS work-up. Patients should receive an EKG upon arrival to the ED
which, typically shows signs of ischemia or injury. EKG findings on initial
EKG can show elevated ST segments, deep T waves and finally QT
prolongation, which is very similar to the pathogenesis of an EKG in acute
myocardial infarction, although recent studies have shown more varied
presentations. Troponins will be elevated in patients due to injury to the
myocardium. The elevations do not peak as they do in a STEMI but there is a
moderate amount of elevation present. To diagnose Takotsubo’s, a patient will
need a cardiac catherization and an echocardiogram. The cardiac catherization is
performed to rule out occlusive disease. The criteria for performing a
catherization is much like the criteria for a typical acute coronary syndrome
diagnostic work up. If a patient is found to have no occlusive disease,
Takotsubo’s may be more likely a diagnosis. The echocardiogram in these
patients will show a decreased ejection fraction with abnormal wall motion. The
akinesis of the heart musculature will extend to more than one specific coronary
artery distribution. Performing a catherization is important to rule out multi
vessel disease which can present as abnormal wall motion in more than one area
of the heart. The condition has seen a significant rise in diagnosis since it was
first described. This is believed to be due to the increased awareness of the
condition. Although the table above gives guidelines for diagnosis of this
condition there is not one specific set of criteria that is used for diagnosis.
Reviewing multiple articles, the common themes are: myocardial injury without
significant obstructive disease with reversible akinesis of the ventricular walls.
The pathophysiology of this disease is currently evolving at this time but the
leading hypothesis for this condition is thought to be an increase in
catecholamines.

Takotsubo cardiomyopathy or its more infamous moniker broken
heart syndrome, was first discussed in 1990 in Japan and has been
increasingly diagnosed since that time. Symptoms are often
preceded by a physical or emotional stress. Patients typically present
as someone with acute coronary syndrome. Patients are eventually
diagnosed with Takotsubo’s after a thorough work up which includes
EKG, troponins, echocardiogram and coronary angiography. It is
characterized by ventricular wall motion abnormalities with normal
coronary arteries. The patients can develop sequelae of acute
coronary syndrome such as shock and pulmonary edema. The
pathogenesis of the disease is not well known, but it is believed that
catecholamines play an integral role. Most patients recover to
baseline and treatment is usually supportive unless there are
sequelae present that require directed therapy.

Case Description
The patient is a 71 y/o female with hx of HTN, polycythemia vera,
hyperlipidemia and diabetes mellitus that presents of diarrhea with
occasional rectal bleeding for 1 week. She was seen for similar
issues 2 months prior with negative colonoscopy. On work up in the
ED, she was found to have significant hypokalemia,
hypomagnesaemia with prolonged QT on EKG. She was started on
IV electrolyte replacement and admitted for further repletion. On
hospital day 1 the patient complained of chest pressure that cleared
with coughing. EKG at that time was negative for acute changes but
troponins were elevated. She was subsequently started on heparin
for an NSTEMI. Repeat EKG showed changes in the anterior leads
with continued rising of troponins. The patient was also found to
have new pulmonary edema on the chest x-ray with significantly
elevated BNP and was transferred to the ICU for continued
management. She had an echocardiogram which showed dyskinesis
of the mid and distal segments of the left ventricle and an EF of
35%. Her cardiac catherization showed no obstructive coronary
artery disease. She was treated for acute pulmonary edema with
lasix, metoprolol, imdur, and hydralyzine. The patient’s pulmonary
edema and shortness of breath resolved on hospital day 5 and she
was discharged home on hospital day 7 with a new prescription for
lasix but continued her previous blood pressure medications. Patient
was advised to follow up with her PCP, nephrologist,
gastroenterologist and cardiologist.

Discussion

Left ventriculogram demonstrating the classic pattern of takotsubo cardiomyopathy;akinesis of the left
ventricular apex with preserved function at the base.

Table 1. Mayo Clinic Criteria for ABS/TTC20
1. Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid-segments
with or without apical involvement; the regional wall
motion abnormalities extend beyond a single epicardial vascular distribution; a stressful
trigger is often, but not always present.*
2. Absence of obstructive coronary disease or angiographic evidence of acute plaque
rupture.†
3. New electrocardiographic abnormalities (either ST-segment elevation and/or T-wave
inversion) or modest elevation in cardiac troponin.
4. Absence of:
a. Pheochromocytoma
b. Myocarditis
ABS, apical ballooning syndrome; TTC, takotsubo cardiomyopathy; ACS, acute
coronary syndrome.
*There are rare exceptions to these criteria such as those patients in whom the regional
wall motion abnormality is limited to a single coronary territory.
†It is possible that a patient with obstructive coronary atherosclerosis may also develop
ABS. However, this is very rare in our experience and in the published literature,
perhaps because such cases are misdiagnosed as ACS.
In both of the above circumstances, the diagnosis of ABS should be made with caution
and a clear stressful precipitating trigger must be sought.

Conclusion
As more people are diagnosed with Takotsubo cardiomyopathy, I believe that
there will be a better understanding of the pathophysiology. Due to the initial
presentation of this disease being similar to an acute myocardial infarction,
therapy and work up is directed as such. This disease is diagnosed through a
thorough diagnostic work up and after other life threatening diseases are ruled
out. Although life threatening complications can occur such as CHF, cardiogenic
shock, thrombosis, arrhythmias and ventricular rupture, patients generally
receive supportive care and have a favorable prognosis. As further research
progresses, management of this condition will undoubtedly improve.
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